Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?
about
Trials with 'epigenetic' drugs: an updateUnderstanding, recognizing, and managing toxicities of targeted anticancer therapies.Cardio-Oncology: Cancer Therapy-related Cardiovascular Complications in a Molecular Targeted Era: New Concepts and Perspectives.How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?Lifestyle interventions for cardiovascular risk reduction in women with breast cancer.Cardiomyocyte ryanodine receptor degradation by chaperone-mediated autophagyCardiac side effects of anticancer treatments: new mechanistic insightsCardiotoxicity associated with targeting kinase pathways in cancer.Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.The Notch pathway: a novel target for myocardial remodelling therapy?Anti-angiogenic activity of thienopyridine derivative LCB03-0110 by targeting VEGFR-2 and JAK/STAT3 Signalling.Distal Medullary Canal Decompression in Long Stem Hip Replacement in Long Bone Metastasis: Does it Reduce Cardiopulmonary Complications?Structural basis of focal adhesion targeting domain-mediated signaling in cardiac hypertrophy.Cardiovascular Toxicities of Small Molecule Tyrosine Kinase Inhibitors: An Opportunity for Systems-Based Approaches.
P2860
Q27000542-CC226226-5224-48B7-A4D4-1AAFBF2D4A37Q33408049-B08F7F97-B5D8-4136-8DBA-08A2DA30CE4DQ33807542-AB1AC675-2061-4B0C-899C-9E3BAD2DE84EQ35036150-E42F4069-949B-4911-A63B-FA91CB3F5F8CQ35878469-D84BA3DA-58FB-4CD1-BC39-2EE62056E7B0Q36786539-05F7E8A2-74E9-400F-B6C8-376BFD92B84DQ36957758-EE10DF25-220D-4C17-8306-138AB46E54C4Q37823035-1A21E187-CE06-441E-8BFC-5ECE16670C57Q38001376-BE964ECC-0792-42CF-8773-22974318C3C5Q38223705-57B221BC-74E7-49B1-A389-F1185E933650Q38895275-2F2FCFAE-7071-46CA-862E-75C8708FFCC0Q49418085-FAE70539-209F-4587-BE83-0B273FB52258Q50863322-C0D2E124-2F88-4060-8944-5B4237F9E451Q51348764-57482AC7-429E-4FA5-85B8-FF9E247A3614
P2860
Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging anticancer therapeuti ...... m: is there cause for concern?
@en
Emerging anticancer therapeuti ...... m: is there cause for concern?
@nl
type
label
Emerging anticancer therapeuti ...... m: is there cause for concern?
@en
Emerging anticancer therapeuti ...... m: is there cause for concern?
@nl
prefLabel
Emerging anticancer therapeuti ...... m: is there cause for concern?
@en
Emerging anticancer therapeuti ...... m: is there cause for concern?
@nl
P2093
P2860
P1433
P1476
Emerging anticancer therapeuti ...... m: is there cause for concern?
@en
P2093
Douglas B Sawyer
Laura Pentassuglia
Xuyang Peng
P2860
P304
P356
10.1161/CIRCRESAHA.109.211276
P577
2010-04-01T00:00:00Z